An Adaptive Dose Escalation and Expansion Basket Trial to Explore the Safety, Pharmacology, and Clinical Activity of TGD001 in Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) and Other Thrombotic Microangiopathies
TG1-CL-301
Phase 2 other active
Quick answer
An Adaptive Dose Escalation and Expansion Basket Trial to Explore the Safety, Pharmacology, and Clinical Activity of TGD001 in Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) and Other Thrombotic Microangiopathies for Immune-Mediated Thrombotic Thrombocytopenic Purpura, Thrombotic microangiopathy is a Phase 2 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Immune-Mediated Thrombotic Thrombocytopenic Purpura, Thrombotic microangiopathy
- Phase
- Phase 2
- Modality
- other
- Status
- active